Company intelligence / Profile preview

Maverix Medical

Menlo Park, California, USA

Ownership: Private
Development stage: Preclinical

Overview

Maverix Medical offers a portfolio of blood-based diagnostic tests and advanced biopsy devices to improve early detection and management of lung cancer. The company recently expanded its capabilities by acquiring Cirrus Bio to build a multiomic diagnostics platform. Its minimally invasive palliative care devices aim to enhance quality of life for patients diagnosed after Stage I. Clinical results or trial data are not specifically disclosed in public sources.

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic test
Industry: Molecular Diagnostics

Partnerships

Ajax HealthKKRHologic Inc.

Beyond the preview

Go deeper on Maverix Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maverix Medical.

Explore the full profile